Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 288
Filter
1.
Phys Rev Lett ; 116(4): 043601, 2016 Jan 29.
Article in English | MEDLINE | ID: mdl-26871329

ABSTRACT

We report the observation of efficient and low-noise frequency conversion between two microwave modes, mediated by the motion of a mechanical resonator subjected to radiation pressure. We achieve coherent conversion of more than 10^{12} photons/s with a 95% efficiency and a 14 kHz bandwidth. With less than 10^{-1} photons·s^{-1}·Hz^{-1} of added noise, this optomechanical frequency converter is suitable for quantum state transduction. We show the ability to operate this converter as a tunable beam splitter, with direct applications for photon routing and communication through complex quantum networks.

2.
Phys Rev X ; 5(4): 041037, 2015.
Article in English | MEDLINE | ID: mdl-27057422

ABSTRACT

By coupling a macroscopic mechanical oscillator to two microwave cavities, we simultaneously prepare and monitor a nonclassical steady state of mechanical motion. In each cavity, correlated radiation pressure forces induced by two coherent drives engineer the coupling between the quadratures of light and motion. We, first, demonstrate the ability to perform a continuous quantum nondemolition measurement of a single mechanical quadrature at a rate that exceeds the mechanical decoherence rate, while avoiding measurement backaction by more than 13 dB. Second, we apply this measurement technique to independently verify the preparation of a squeezed state in the mechanical oscillator, resolving quadrature fluctuations 20% below the quantum noise.

3.
Perfusion ; 29(5): 443-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24534886

ABSTRACT

Cerebral embolization during pediatric cardiac surgery may be an underappreciated source of subsequent neurodevelopmental impairment. Transcranial Doppler ultrasound is a neuromonitoring tool that can provide intraoperative surveillance for cerebral embolization. We hypothesized that increased cerebral embolic signals detected during infant cardiac surgery would be associated with worse neurodevelopmental outcomes at follow-up. A study group of 24 children who underwent infant cardiac surgery with transcranial Doppler detection of cerebral embolic signals returned at intermediate follow-up for standardized neurodevelopmental assessment. The children were evaluated using two neurocognitive tests and the parents completed two questionnaires regarding observed behavior. Statistical analysis assessed for correlation between the number of cerebral embolic signals at surgery and the results of the neurodevelopmental assessment. Of the 67 test parameters analyzed, five showed a significant association with the number of embolic signals, yet, all in the contrary direction of the clinical hypothesis, likely representing a Type I error. Thus, in this small cohort of patients, the number of cerebral embolic signals detected during infant cardiac surgery was not shown to be associated with worse neurodevelopmental outcomes at intermediate follow-up. A larger study is probably necessary to ascertain the potential influence of cerebral embolic signals on eventual neurologic outcomes in children. The clinical relevance of cerebral embolic signals during pediatric cardiac surgery remains undetermined and deserves further investigation.


Subject(s)
Cardiac Surgical Procedures , Cerebrovascular Circulation , Child Development , Embolization, Therapeutic , Heart Defects, Congenital , Ultrasonography, Doppler, Transcranial , Cognition , Follow-Up Studies , Heart Defects, Congenital/physiopathology , Heart Defects, Congenital/therapy , Humans , Infant , Infant, Newborn , Male
4.
Perfusion ; 26 Suppl 1: 35-9, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21933820

ABSTRACT

This review on the benefits of pulsatile flow includes not only experimental and clinical data, but also attempts to further illuminate the major factors as to why this debate has continued during the past 55 years. Every single component of the cardiopulmonary bypass (CPB) circuitry is equally important for generating adequate quality of pulsatility, not only the pump. Therefore, translational research is a necessity to select the best components for the circuit. Generation of pulsatile flow depends on an energy gradient; precise quantification in terms of hemodynamic energy levels is, therefore, a necessity, not an option. Comparisons between perfusion modes should be done after these basic steps have been taken. We have also included experimental and clinical data for direct comparisons between the perfusion modes. In addition, we included several suggestions for future clinical trials for other interested investigators.


Subject(s)
Cardiopulmonary Bypass/methods , Hemodynamics , Pulsatile Flow , Adolescent , Cardiopulmonary Bypass/adverse effects , Child , Child, Preschool , Female , Humans , Infant , Male , Translational Research, Biomedical/methods
5.
Perfusion ; 26(4): 276-83, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21558147

ABSTRACT

OBJECTIVE: To construct an ideal extracorporeal life support (ECLS) circuit in terms of hemodynamic performance, each component of the circuit should be evaluated. Most cannulae manufacturers evaluate their products using water as the priming solution. We conducted this study to evaluate the different sizes of arterial and venous cannulae in a simulated neonatal ECLS circuit primed with human blood. METHODS: The simulated neonatal ECLS circuit was composed of a Capiox Baby RX05 oxygenator, a Rotaflow centrifugal pump and a heater & cooler unit. Three Medtronic Bio-Medicus arterial cannulae (8Fr, 10Fr, 12Fr) and three venous cannulae (10Fr, 12Fr, 14Fr) were tested in seven combinations (8A-10V, 8A-12V, 10A-10V, 10A-12V, 10A-14V, 12A-12V, 12A-14V). All the experiments were conducted using human blood at a hematocrit of 40% and at a constant temperature of 37°C. The "tip to tip" priming volume of the entire circuit was 135ml. The blood volume of the pseudo patient was 500ml. RESULTS: Flow rates increased linearly with increasing size in both venous and arterial cannulae at the same pump speeds. The increase in flow rate was greater when changing the arterial cannulae (next size larger) compared to changing the venous cannulae (next size larger). The pressure drops of the arterial cannula were correlated with the flow rates, regardless of the pseudo patient pressure and the venous cannula used simultaneously. CONCLUSIONS: The results show the difference in flow ranges and pressure drops of seven combinations of arterial and venous cannulae. It also suggests that the arterial cannula, not the venous cannula, has greater impact on the flow rate when a centrifugal pump is used in a neonatal ECLS circuit. The results of this study have been translated to further advancing the clinical practice in our institution.


Subject(s)
Catheterization/instrumentation , Catheters , Extracorporeal Circulation/instrumentation , Hemodynamics , Arteries , Catheterization/methods , Extracorporeal Circulation/methods , Humans , Infant, Newborn , Veins
6.
J Neurochem ; 95(4): 1015-22, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16190880

ABSTRACT

We looked at the possible interactions between astrocytes and neurones during reperfusion using an in vitro model of ischaemia-reperfusion injury, as a controlled environment that lends itself easily to manipulation of the numerous variables involved in such an insult. We constructed a chamber in which O2 can be lowered to a concentration of 1 microm and developed a primary cortical neuronal culture that is 99% pure and can survive to at least 10 days in vitro. We also established a novel system for the co-culture of astrocytes and neurones in order to study the communication between these cells in a manner that allows the complete separation of one cell type from another. Neurone cultures showed profound cell death following an ischaemic period of only 15 min. We co-cultured neurones that had been subjected to a 15-min ischaemic insult with either non-insulted astrocytes or astrocyte-conditioned medium during the reperfusion stage. Both astrocytes and astrocyte-conditioned medium enhanced neuronal survival. Our data also suggest that astrocyte-sourced neuronal glutathione synthesis may play a role in preventing neuronal death.


Subject(s)
Astrocytes/physiology , Cell Communication/physiology , Cerebral Cortex/cytology , Glucose/deficiency , Hypoxia/physiopathology , Neurons/physiology , Analysis of Variance , Animals , Animals, Newborn , Cell Survival/physiology , Cells, Cultured , Chromatography, High Pressure Liquid/methods , Coculture Techniques/methods , Glutathione/analysis , Immunohistochemistry/methods , Rats , Tinea
7.
Brain Res ; 1036(1-2): 1-6, 2005 Mar 02.
Article in English | MEDLINE | ID: mdl-15725395

ABSTRACT

The antioxidant glutathione (GSH) plays an important role in protecting the mitochondrial electron transport chain (ETC) from damage by oxidative stress in astrocytes and neurones. Neurones co-cultured with astrocytes have greater GSH levels, compared to neurones cultured alone, leading to the hypothesis that astrocytes play a key role in brain GSH metabolism by supplying essential GSH precursors to neurones. A previous study has postulated that damage to the ETC following exposure to reactive nitrogen species (RNS) is less in co-cultured neurones, compared to neurones cultured alone, because of the greater GSH levels in the former cells. To investigate this further, primary culture rat neurones were co-cultured with either rat astrocytes activated with IFN-gamma and LPS to produce NO, or NO-generating astrocytes that had been depleted of intracellular GSH by 87% following incubation with the GSH synthesis inhibitor L-buthionine-S,R-sulfoximine (L-BSO). Neurones incubated with NO-generating astrocytes depleted of GSH were unable to elevate GSH levels, unlike neurones co-cultured with NO-generating astrocytes. Complexes II + III and IV of the neuronal ETC were significantly inhibited following exposure to NO-generating astrocytes depleted of GSH. No ETC damage was observed in neurones co-cultured with NO-generating astrocytes. Although neurones co-cultured with GSH depleted astrocytes did not increase cellular GSH levels, the activity of glutamate cysteine ligase (GCL), the rate-limiting enzyme of GSH synthesis, was increased by 218%, compared to neurones cultured with control astrocytes. This suggests that neuronal GCL activity could be modulated when GSH metabolism is inhibited in neighboring astrocytes.


Subject(s)
Astrocytes/metabolism , Glutamate-Cysteine Ligase/metabolism , Glutathione/metabolism , Neurons/metabolism , Nitric Oxide/metabolism , Oxidative Stress/physiology , Animals , Animals, Newborn , Astrocytes/drug effects , Brain/metabolism , Brain/physiopathology , Cell Communication/drug effects , Cell Communication/physiology , Cells, Cultured , Coculture Techniques , Electron Transport Chain Complex Proteins/drug effects , Electron Transport Chain Complex Proteins/metabolism , Enzyme Inhibitors/pharmacology , Glutathione/antagonists & inhibitors , Inflammation Mediators/pharmacology , Neurons/drug effects , Nitric Oxide/pharmacology , Oxidative Stress/drug effects , Rats , Rats, Wistar , Up-Regulation/drug effects , Up-Regulation/physiology
8.
J Neurochem ; 86(1): 228-37, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12807442

ABSTRACT

Primary culture rat astrocytes exposed to the long acting nitric oxide donor (Z)-1-[2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NO) for 24 h approximately double their concentration of glutathione (GSH) and show no sign of cell death. In contrast, GSH was depleted by 48%, and significant loss of mitochondrial respiratory chain complex activity and cell death were observed in primary culture rat neurones subjected to DETA-NO for 18 h. Northern blot analysis suggested that mRNA amounts of both subunits of glutamate-cysteine ligase (GCL), the rate-limiting enzyme in GSH synthesis, were elevated in astrocytes following nitric oxide (NO) exposure. This correlated with an increase in astrocytic GCL activity. Neurones on the other hand did not exhibit increased GCL activity when exposed to NO. In addition, the rate of GSH efflux was doubled and gamma-glutamyltranspeptidase (gamma-GT) activity was increased by 42% in astrocytes treated with NO for 24 h. These results suggest that astrocytes, but not neurones, up-regulate GSH synthesis as a defence mechanism against excess NO. It is possible that the increased rate of GSH release and activity of gamma-GT in astrocytes may have important implications for neuroprotection in vivo by optimizing the supply of GSH precursors to neurones in close proximity.


Subject(s)
Astrocytes/metabolism , Glutathione/metabolism , Mitochondria/drug effects , Neurons/metabolism , Nitric Oxide/metabolism , Animals , Astrocytes/cytology , Astrocytes/drug effects , Cells, Cultured , Electron Transport/drug effects , Glutamate-Cysteine Ligase/drug effects , Glutamate-Cysteine Ligase/genetics , Glutamate-Cysteine Ligase/metabolism , Mitochondria/metabolism , Neurodegenerative Diseases/etiology , Neurons/cytology , Neurons/drug effects , Neuroprotective Agents , Nitric Oxide/pharmacology , Nitric Oxide Donors/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Wistar , Triazenes/pharmacology , gamma-Glutamyltransferase/drug effects , gamma-Glutamyltransferase/metabolism
9.
Neurobiol Dis ; 10(3): 258-67, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12270688

ABSTRACT

Beta-amyloid deposition and compromised energy metabolism both occur in vulnerable brain regions in Alzheimer's disease. It is not known whether beta-amyloid is the cause of impairment of energy metabolism, nor whether impaired energy metabolism is specific to neurons. Our results, using primary neuronal cultures, show that 24-h incubation with A beta(25-35) caused a generalized decrease in the specific activity of mitochondrial enzymes per milligram of cellular protein, induced mitochondrial swelling, and decreased total mitochondrial number. Incubation with A beta(25-35) decreased ATP concentration to 58% of control in neurons and 71% of control in astrocytes. Levels of reduced glutathione were also lowered by A beta(25-35) in both neurons (from 5.1 to 2.9 nmol/mg protein) and astrocytes (from 25.2 to 14.9 nmol/mg protein). We conclude that 24-h treatment with extracellular A beta(25-35) causes mitochondrial dysfunction in both astrocytes and neurons, the latter being more seriously affected. In astrocytes mitochondrial impairment was confined to complex I inhibition, whereas in neurons a generalized loss of mitochondria was seen.


Subject(s)
Amyloid beta-Peptides/pharmacology , Cerebral Cortex/drug effects , Mitochondria/drug effects , Mitochondria/pathology , Neurons/drug effects , Neurons/pathology , Peptide Fragments/pharmacology , Animals , Animals, Newborn , Astrocytes/drug effects , Astrocytes/enzymology , Astrocytes/pathology , Cells, Cultured , Cerebral Cortex/enzymology , Cerebral Cortex/pathology , Embryo, Mammalian , Mitochondria/metabolism , Mitochondrial Swelling/drug effects , Mitochondrial Swelling/physiology , Neurons/enzymology , Rats
10.
Eur J Neurosci ; 15(3): 458-64, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11876773

ABSTRACT

Cytokine-stimulated astrocytes produce nitric oxide, which can inhibit components of the mitochondrial respiratory chain. We have previously demonstrated that prolonged exposure (48 h) to rat astrocytic nitric oxide damages complexes II--III and IV of neighbouring rat neurons in coculture, resulting in neuronal death. Expanding on these observations, we have now shown that the NMDA receptor antagonist, MK-801, prevents this damage, suggesting involvement of glutamate. We postulate that astrocyte-derived nitric oxide stimulates release of neuronal glutamate. Indeed we demonstrate that neurons incubated with nitric oxide-generating astrocytes display enhanced glutamate release. Furthermore, direct exposure to the nitric oxide donor, DETA-NONOate resulted in a loss of activity of all the neuronal mitochondrial complexes, which was again prevented by MK-801. Thus, nitric oxide, generated by both cytokine-stimulated astrocytes and by a nitric oxide donor, causes activation of the NMDA receptor leading to damage to the neuronal mitochondrial respiratory chain. Glutamate exposure is known to damage the neuronal mitochondrial respiratory chain via neuronal nitric oxide synthase. Therefore, we propose that astrocyte-derived nitric oxide is capable of eliciting neuronal glutamate release, which in turn activates the neuronal NMDA receptor and stimulates further formation of reactive nitrogen species via neuronal nitric oxide synthases, leading to mitochondrial damage and neuronal death. Our findings support the hypothesis that glutamate, reactive nitrogen species and mitochondrial dysfunction may have a role in the neurodegenerative process.


Subject(s)
Cell Death/physiology , Electron Transport/physiology , Mitochondria/metabolism , Neurons/metabolism , Nitric Oxide/metabolism , Reactive Nitrogen Species/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Cell Death/drug effects , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Central Nervous System/metabolism , Central Nervous System/physiopathology , Electron Transport/drug effects , Excitatory Amino Acid Antagonists/pharmacology , Glutamic Acid/metabolism , L-Lactate Dehydrogenase/drug effects , L-Lactate Dehydrogenase/metabolism , Mitochondria/drug effects , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/physiopathology , Neurons/drug effects , Nitric Oxide Donors/pharmacology , Rats , Receptors, N-Methyl-D-Aspartate/drug effects
11.
J Neurochem ; 80(1): 91-100, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11796747

ABSTRACT

Disrupted energy metabolism, in particular reduced activity of cytochrome oxidase (EC 1.9.3.1), alpha-ketoglutarate dehydrogenase (EC 1.2.4.2) and pyruvate dehydrogenase (EC 1.2.4.1) have been reported in post-mortem Alzheimer's disease brain. beta-Amyloid is strongly implicated in Alzheimer's pathology and can be formed intracellularly in neurones. We have investigated the possibility that beta-amyloid itself disrupts mitochondrial function. Isolated rat brain mitochondria have been incubated with the beta-amyloid alone or together with nitric oxide, which is known to be elevated in Alzheimer's brain. Mitochondrial respiration, electron transport chain complex activities, alpha-ketoglutarate dehydrogenase activity and pyruvate dehydrogenase activity have been measured. Beta-amyloid caused a significant reduction in state 3 and state 4 mitochondrial respiration that was further diminished by the addition of nitric oxide. Cytochrome oxidase, alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase activities were inhibited by beta-amyloid. The K(m) of cytochrome oxidase for reduced cytochrome c was raised by beta-amyloid. We conclude that beta-amyloid can directly disrupt mitochondrial function, inhibits key enzymes and may contribute to the deficiency of energy metabolism seen in Alzheimer's disease.


Subject(s)
Amyloid beta-Peptides/pharmacology , Brain/metabolism , Enzymes/metabolism , Mitochondria/metabolism , Oxygen Consumption/drug effects , Animals , Brain/enzymology , Drug Combinations , Electron Transport/drug effects , Male , Mitochondria/enzymology , Nitric Oxide/pharmacology , Rats , Rats, Wistar
13.
Neurochem Res ; 26(6): 739-64, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11519733

ABSTRACT

It is becoming increasingly evident that the mitochondrial genome may play a key role in neurodegenerative diseases. Mitochondrial dysfunction is characteristic of several neurodegenerative disorders, and evidence for mitochondria being a site of damage in neurodegenerative disorders is partially based on decreases in respiratory chain complex activities in Parkinson's disease, Alzheimer's disease, and Huntington's disease. Such defects in respiratory complex activities, possibly associated with oxidant/antioxidant balance perturbation, are thought to underlie defects in energy metabolism and induce cellular degeneration. Efficient functioning of maintenance and repair process seems to be crucial for both survival and physical quality of life. This is accomplished by a complex network of the so-called longevity assurance processes, which are composed of genes termed vitagenes. A promising approach for the identification of critical gerontogenic processes is represented by the hormesis-like positive effect of stress. In the present review, we discuss the role of energy thresholds in brain mitochondria and their implications in neurodegeneration. We then review the evidence for the role of oxidative stress in modulating the effects of mitochondrial DNA mutations on brain age-related disorders and also discuss new approaches for investigating the mechanisms of lifetime survival and longevity.


Subject(s)
Aging/physiology , Brain/physiology , Brain/physiopathology , Longevity , Mitochondria/physiology , Neurodegenerative Diseases/physiopathology , Animals , Humans
14.
Aviat Space Environ Med ; 72(6): 539-45, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11396560

ABSTRACT

UNLABELLED: The current training program for hypoxia familiarization requires a low-pressure chamber that places aviator trainees at risk for decompression sickness. A cost-effective reduced oxygen-breathing (ROB) paradigm that decreases oxygen (O2) concentration leading to normobaric hypoxia was assessed as an alternative to the hypobaric chamber. PURPOSE: To help establish the validity of the ROB paradigm, this report documents cognitive performance, cardiopulmonary and subjective changes during ROB exposure. METHODS: Performance on a two-dimensional tracking task, as well as BP, heart rate, end-tidal carbon dioxide (ETCO2), O2 saturation, and subjective reports of hypoxia symptoms were observed in 12 U.S. Navy divers during exposure to normoxic air followed by one of four experimental gas mixtures per session. All participants received all gas conditions that differed in their relative concentrations of O2 and nitrogen (6.20/93.80, 7.00/93.00, 7.85/92.15, and 20.85/79.15% O2/N2). RESULTS: ROB caused increases in tracking task error (p < 0.0001). ROB also increased heart rate (p < 0.001) and systolic BP (p = 0.004), and decreased ETCO2 and O2 saturation (p < 0.0001). Finally, subjects responded to ROB-induced hypoxia with higher subjective symptom ratings (p < 0.0001). CONCLUSIONS: These data are consistent with those expected from hypoxic states and support the validity of the ROB paradigm for hypoxia training. Future validation studies comparing a ROB device with hypobaric chambers are needed.


Subject(s)
Adaptation, Physiological , Aerospace Medicine , Blood Pressure/physiology , Breathing Exercises , Cognition/physiology , Decompression Sickness/prevention & control , Diving/adverse effects , Environmental Exposure , Heart Rate/physiology , Hypoxia/physiopathology , Hypoxia/psychology , Military Personnel , Psychomotor Performance/physiology , Adult , Cost-Benefit Analysis , Decompression Sickness/etiology , Diving/physiology , Diving/psychology , Humans , Male , Middle Aged , Risk Factors , United States
15.
Brain Res ; 894(2): 181-8, 2001 Mar 16.
Article in English | MEDLINE | ID: mdl-11251191

ABSTRACT

The process of nitric-oxide (NO)-induced cellular toxicity may involve energy deprivation since the radical is reported to prevent both mitochondrial oxidative phosphorylation and glycolysis. In order to determine whether these processes are important in NO-induced blood-brain barrier (BBB) dysfunction, we used a cell culture model of the BBB and compared the effects of gaseous NO, potassium cyanide (KCN, a mitochondrial respiratory chain inhibitor) and iodoacetate [IA, an inhibitor of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH)] on endothelial cell ATP content, GAPDH activity and barrier integrity. NO lead to a rapid breakdown in model barrier integrity and resulted in a reduction in endothelial cell ATP content and GAPDH activity. KCN had no effect on endothelial cell ATP content or barrier integrity, while IA, at a concentration that completely blocked endothelial cell GAPDH activity, resulted in a rapid decline in ATP content but did not lead to a decline in barrier integrity until at least 2 h of exposure. These results indicate that inhibition of endothelial cell GAPDH activity rather than mitochondrial respiration causes an energy deficiency and delayed barrier dysfunction. However, the rapid detrimental effects of gaseous NO on barrier integrity cannot be fully explained by endothelial cell energy depletion and may be related to the actions of the free radical and its products on cellular lipids.


Subject(s)
Blood-Brain Barrier/physiology , Endothelium, Vascular/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenases/antagonists & inhibitors , Nitric Oxide/metabolism , Adenosine Triphosphate/metabolism , Blood-Brain Barrier/drug effects , Cells, Cultured , Electric Impedance , Endothelium, Vascular/cytology , Enzyme Inhibitors/pharmacology , Free Radicals/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Humans , In Vitro Techniques , Iodoacetates/pharmacology , Lipid Peroxidation/physiology , Oxidative Phosphorylation/drug effects , Oxidative Stress/drug effects , Oxidative Stress/physiology , Potassium Cyanide/pharmacology , Superoxides/metabolism , Umbilical Veins/cytology
16.
J Neurochem ; 75(2): 694-700, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10899944

ABSTRACT

Cytokine-stimulated astrocytes produce nitric oxide (NO), which, along with its metabolite peroxynitrite (ONOO(-)), can inhibit components of the mitochondrial respiratory chain. We used astrocytes as a source of NO/ONOO(-) and monitored the effects on neurons in coculture. We previously demonstrated that astrocytic NO/ONOO(-) causes significant damage to the activities of complexes II/III and IV of neighbouring neurons after a 24-h coculture. Under these conditions, no neuronal death was observed. Using polytetrafluoroethane filters, which are permeable to gases such as NO but impermeable to NO derivatives, we have now demonstrated that astrocyte-derived NO is responsible for the damage observed in our coculture system. Expanding on these observations, we have now shown that 24 h after removal of NO-producing astrocytes, neurons exhibit complete recovery of complex II/III and IV activities. Furthermore, extending the period of exposure of neurons to NO-producing astrocytes does not cause further damage to the neuronal mitochondrial respiratory chain. However, whereas the activity of complex II/III recovers with time, the damage to complex IV caused by a 48-h coculture with NO-producing astrocytes is irreversible. Therefore, it appears that neurons can recover from short-term damage to mitochondrial complex II/III and IV, whereas exposure to astrocytic-derived NO for longer periods causes permanent damage to neuronal complex IV.


Subject(s)
Astrocytes/physiology , Mitochondria/physiology , Neurons/physiology , Nitric Oxide/physiology , Oxygen Consumption/physiology , Animals , Animals, Newborn , Astrocytes/cytology , Cell Survival , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/physiology , Citrate (si)-Synthase/metabolism , Coculture Techniques , Electron Transport Complex II , Electron Transport Complex III/metabolism , Electron Transport Complex IV/metabolism , Kinetics , Multienzyme Complexes/metabolism , NADH Dehydrogenase/metabolism , Neurons/cytology , Nitrates/physiology , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Oxidants , Oxidoreductases/metabolism , Rats , Rats, Wistar , Succinate Dehydrogenase/metabolism
17.
J Neurochem ; 73(6): 2563-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10582619

ABSTRACT

Mutations in GTP-cyclohydrolase I (GTP-CH) have been identified as causing a range of inborn errors of metabolism, including dopa-responsive dystonia. GTP-CH catalyses the first step in the biosynthesis of tetrahydrobiopterin (BH4), a cofactor necessary for the synthesis of catecholamines and serotonin. Current therapy based on monoamine neurotransmitter replacement may be only partially successful in correcting the neurological deficits. The reason might be that BH4 is also a cofactor for nitric oxide synthase. Using a strain of mutant GTP-CH-deficient (hph-1) mice, we demonstrate that in addition to impaired monoamine metabolism, BH4 deficiency is also associated with diminished nitric oxide synthesis in the brain (as evaluated by measuring the levels of cyclic GMP), when compared with wild-type animals. We have found a decline in the levels of BH4 with age in all animals, but no gender-related differences. We found a strong association between the levels of BH4 and cyclic GMP in hph-1 mice but not in wild-type animals. We also demonstrate that acute peripheral administration of BH4 (100 micromol/kg s.c.) in hph-1 mice significantly elevated the brain BH4 concentration and subsequently cyclic GMP levels in cerebellum, with peaks at 2 and 3 h, respectively. We suggest that BH4 administration should be considered in BH4 deficiency states in addition to monoamine replacement therapy.


Subject(s)
Biopterins/analogs & derivatives , Brain/drug effects , Cyclic GMP/physiology , Dystonic Disorders/metabolism , GTP Cyclohydrolase/physiology , Nerve Tissue Proteins/physiology , Nitric Oxide/physiology , Second Messenger Systems/physiology , Animals , Biopterins/pharmacology , Brain/metabolism , Cerebellum/drug effects , Cerebellum/metabolism , Dystonic Disorders/genetics , GTP Cyclohydrolase/deficiency , GTP Cyclohydrolase/genetics , Mice , Mice, Neurologic Mutants , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type I , Prosencephalon/drug effects , Prosencephalon/metabolism , Second Messenger Systems/drug effects , Serotonin/metabolism , Stimulation, Chemical
18.
FEBS Lett ; 457(1): 131-4, 1999 Aug 20.
Article in English | MEDLINE | ID: mdl-10486579

ABSTRACT

Defects in mitochondrial oxidative metabolism, in particular decreased activity of cytochrome c oxidase, have been demonstrated in Alzheimer's disease, and after the expression of the amyloid precursor protein (APP) in cultured cells, suggesting that mitochondria might be involved in beta-amyloid toxicity. Recent evidence suggests that the proteolysis of APP to generate beta-amyloid is at least in part intracellular, preceding the deposition of extracellular fibrils. We have therefore investigated the effect of incubation of isolated rat brain mitochondria with the beta-amyloid fragment 25-35 (100 microM) on the activities of the mitochondrial respiratory chain complexes I, II-III, IV (cytochrome c oxidase) and citrate synthase. The peptide caused a rapid, dose-dependent decrease in the activity of complex IV, white it had no effect on the activities on any of the other enzymes tested. The reverse sequence peptide (35-25) had no effect on any of the activities measured. We conclude that inhibition of mitochondrial complex IV might be a contributing factor to the pathogenesis of Alzheimer's disease.


Subject(s)
Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/physiology , Electron Transport Complex IV/metabolism , Mitochondria/metabolism , Animals , Brain/metabolism , Citrate (si)-Synthase/metabolism , Electron Transport/physiology , Electron Transport Complex IV/antagonists & inhibitors , Kinetics , Male , Neurodegenerative Diseases/metabolism , Rats , Rats, Wistar , Time Factors
19.
Neurochem Int ; 35(3): 261-7, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10458656

ABSTRACT

Previously we reported that the co-culture of non-brain vascular endothelial cells with glioma cells leads to the induction of a more differentiated endothelial cell phenotype which exhibits important properties of the blood-brain barrier (BBB). Recognising the potential for improving the model barrier system with agents known to modify the growth and differentiation of cells in culture we examined the effects of four differentiating agents (butyric acid, dexamethasone, retinoic acid, and dimethyl sulfoxide) on barrier function. Of these agents only butyric acid and dexamethasone resulted in an enhancement (depending on the dose used) of transendothelial electrical resistance (barrier function). The greatest effect was observed with butyric acid in a dose-dependent manner and was slow in onset and only occurred in the endothelial/glial cell co-cultures. These data indicate that butyric acid may be a beneficial agent in optimising conditions necessary for induction of BBB properties in in vitro barrier systems.


Subject(s)
Blood-Brain Barrier , Butyric Acid/pharmacology , Endothelium, Vascular/drug effects , Vascular Resistance/drug effects , Cell Differentiation/drug effects , Coculture Techniques , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Endothelium, Vascular/cytology , Endothelium, Vascular/physiology , Glioma/pathology , Models, Biological , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL
...